Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017–2018
2020 · Antiviral Research · 123 citations
https://doi.org/10.1016/j.antiviral.2020.104718
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
498
Citations
5
h-index
5
i10-index
Vicki Gregory is an academic researcher from The Francis Crick Institute. The author has contributed to research in topics: Influenza Virus Research Studies & Respiratory viral infections research & Viral Infections and Immunology Research. The author has an h-index of 5, co-authored 5 publications.
Click to start Chat